February 13, 2025 · Form 4 insider transaction
Shiferman Gregory L. sold 251 shares of SAGE Therapeutics Holdings at $7.18 per share, a transaction worth $1.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
On February 13, 2025, the reporting person vested 750 shares of time-based restricted stock units (RSUs) granted on February 13, 2024 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vests 25% on each grant anniversary date over four years. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.